Table 3.
Group | Percentage of positive cells (%) |
||||
IL-6 | HIF-1α | TNF-α | NF-κB | VEGF | |
R-K | 91.40±1.03 | 84.67±2.47 | 34.67±1.17 | 64.53±1.93 | 89.53±1.86 |
R-O | 71.63±2.06 | 11.63±0.96 | 13.75±0.75 | 16.00±1.16 | 71.75±2.48 |
| |||||
P-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
R-K: recurrent patients from the group not given HBOT; R-O: recurrent patients from the group given HBOT. Data are expressed as mean±SD (R-O group, n=8; R-K group, n=15)